Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decision-making by healthcare payers.

M Levine1, R Taylor, M Ryan

  • 1Centre for Evaluation of Medicines, St Joseph's Healthcare, Hamilton, Ontario, Canada. levinem@mcmaster.ca

Respiratory Medicine
|August 30, 2002
PubMed
Summary

Healthcare payers use health outcomes and economic analyses for resource allocation. Transparent decision-making requires clear evidence, cost-utility analysis, and budget impact assessments, especially with imperfect data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different core promoters possess distinct regulatory activities in the Drosophila embryo.

Genes & development·1998
Same author

In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.

The Journal of pharmacology and experimental therapeutics·1998
Same author

Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.

Bone marrow transplantation·1998
Same author

Ascorbate recycling in human neutrophils: induction by bacteria.

Proceedings of the National Academy of Sciences of the United States of America·1998
Same author

The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.

Thrombosis and haemostasis·1998
Same author

Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion.

Pharmaceutical research·1997

Area of Science:

  • Health Economics
  • Health Policy

Background:

  • Healthcare payers must allocate limited resources to optimize population health.
  • Decision-making is increasingly reliant on health outcomes data and economic analyses.
  • Payers often face pressure to make early decisions with incomplete evidence.

Purpose of the Study:

  • To outline key considerations for healthcare payers in resource allocation and decision-making.
  • To highlight the importance of evidence-based approaches in reimbursement and formulary decisions.
  • To discuss methods for transparent and objective decision-making.

Main Methods:

  • Review of decision-making processes used by healthcare payers globally.
  • Identification of tools such as cost-utility analysis and decision modeling.

Related Experiment Videos

  • Emphasis on comparative effectiveness against current best practices.

    • Main Results:

    • Varying approaches to reimbursement and formulary listing exist across different countries.
    • Cost-utility analysis and decision modeling aid in transparent decision-making.
    • Clear articulation of data assumptions and their impact is crucial.

    Conclusions:

    • Effective healthcare resource allocation requires robust evidence and economic evaluation.
    • Decision-making processes should account for budget impact and equitable distribution.
    • Standardized yet adaptable frameworks are needed for payer decision-making.